Micro insulin pump for mobile diabetes management
The Cellnovo system is the world’s first mobile diabetes management system, including an insulin patch pump, activity monitor, cellular-enabled wireless touchscreen handset with integrated blood glucose meter and automatic connectivity.
The system allows optimal management of insulin injections whilst ensuring extensive freedom of movement for Type 1 diabetes patients. The system has CE mark, and is on the market in the United Kingdom and several European countries.
CEO Sophie Baratte
Advent Contact Raj Parekh
Advent invested in the Series A in 2008. Cellnovo listed on Euronext in July 2015 (EPA:CLNV).
Exited Investments
Success of Cellnovo’s IPO with €31.6 million raised on Euronext in Paris
Press Release. Offer price set at €10.63 per share Market capitalization of €113.6 million Funds to develop production capabilities and accelerate commercial expansion Paris, France, July 9, 2015 –…
Read More
Cellnovo launches first Mobile Diabetes Management System at the ATTD Conference in Vienna, Austria
Press Release. Real-time tracking - an industry first for insulin pump technology Swansea, 5 February 2014 – Cellnovo, the leading innovator in Mobile Diabetes Management technology, today announces the…
Read More
Cellnovo launches world’s first mobile-connected diabetes management system
Press Release. LONDON UK/BARCELONA, SPAIN – February 9, 2012 – Cellnovo today announced both the launch of the world’s only mobile-connected diabetes management system, and the start of the…
Read More
Cellnovo receives 2011 Best MedTech Fundraiser Award
Press Release. LONDON, UK – October 18, 2011 – Cellnovo was named Best Medtech Fundraiser at the recent 2011 OBN Bioscience Awards, an honour that recognises Cellnovo’s success in…
Read More
Frost & Sullivan has announced Cellnovo the winner of its 2011 European Technology Innovation Award in Diabetes Care
Press Release. LONDON, UK - October 4, 2011 - Frost & Sullivan has announced Cellnovo the winner of its 2011 European Technology Innovation Award in Diabetes Care. Cellnovo, a…
Read More
Cellnovo Receives CE Mark Approval for World’s First Mobile Diabetes Management System
Press Release. LONDON, UK – September 19, 2011 – Cellnovo today announced that it has received CE Mark approval for the world’s first mobile diabetes management system, a significant…
Read More
Cellnovo forms worldwide technology alliance with LifeScan
Press Release. LONDON, UK – September 13, 2011 – Cellnovo, developer of the first mobile diabetes management system, today announced a technology alliance with LifeScan, Inc. that will bring…
Read More
Cellnovo secures £30 million in Series B financing to advance new mobile diabetes management system
Press Release. LONDON, UK – February 4, 2011 – Cellnovo, developer of the first mobile diabetes management system, announced today that it raised £30 million ($48.4 million) in a…
Read More
Cellnovo and Home Diagnostics, Inc. form Strategic Alliance
Press Release. Technology integration and expansion of distribution platform drive partnership LONDON, UK AND FORT LAUDERDALE, FLORIDA, USA – Building on a shared vision to simplify diabetes management worldwide,…
Read More
